0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States HIV Therapy Drug Market Report & Forecast 2022-2028
Published Date: November 2022
|
Report Code: QYRE-Auto-4Z12498
Home | Market Reports | Health| Health Conditions| AIDS & HIV
Global HIV Therapy Drug Market Research Report 2022
BUY CHAPTERS

Global and United States HIV Therapy Drug Market Report & Forecast 2022-2028

Code: QYRE-Auto-4Z12498
Report
November 2022
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Market Analysis and Insights: Global and United States HIV Therapy Drug Market
This report focuses on global and United States HIV Therapy Drug market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global HIV Therapy Drug market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028.

Fully considering the economic change by this health crisis, by Type, Multi-Type Combined Drugs accounting for % of the HIV Therapy Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028.

While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the HIV Therapy Drug market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global HIV Therapy Drug Scope and Market Size
HIV Therapy Drug market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global HIV Therapy Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the HIV Therapy Drug market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Multi-Type Combined Drugs
Nucleoside Reverse Transcription Enzyme Inhibitors
Non-Nucleoside Reverse Transcription Enzyme Inhibitors
Hiv Integrated Enzyme Chain Transfer Inhibitor

Segment by Application

Hospital
Clinic
Pharmacy

BY REGION

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

BY COMPANY

ViiV Healthcare
Gilead Sciences, Inc
AbbVie Inc.
Merck & Co
GSK
Bristol-Myers Squibb Company
Theratechnologies Inc.
Roche Holding AG
Teva Pharmaceuticals
Pfizer
Frontier Biotechnologies
Shionogi
Janssen Pharmaceuticals, Inc.
Mylan Pharmaceuticals Inc.
Genentech, Inc.
Boehringer Ingelheim
Cipla
MSD
Abbott
Johnson & Johnson
Biocon Limited
Affine Formulations Limited
IPCA Laboratories
Natco Pharma
Beacon Pharmaceuticals
Julphar Bangladesh
1 Study Coverage
1.1 HIV Therapy Drug Product Introduction
1.2 Global HIV Therapy Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global HIV Therapy Drug Sales in US$ Million for the Year 2017-2028
1.2.2 Global HIV Therapy Drug Sales in Volume for the Year 2017-2028
1.3 United States HIV Therapy Drug Outlook 2017 VS 2022 VS 2028
1.3.1 United States HIV Therapy Drug Sales in US$ Million for the Year 2017-2028
1.3.2 United States HIV Therapy Drug Sales in Volume for the Year 2017-2028
1.4 HIV Therapy Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States HIV Therapy Drug in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of HIV Therapy Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 HIV Therapy Drug Market Dynamics
1.5.1 HIV Therapy Drug Industry Trends
1.5.2 HIV Therapy Drug Market Drivers
1.5.3 HIV Therapy Drug Market Challenges
1.5.4 HIV Therapy Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 HIV Therapy Drug Market Segment by Type
2.1.1 Multi-Type Combined Drugs
2.1.2 Nucleoside Reverse Transcription Enzyme Inhibitors
2.1.3 Non-Nucleoside Reverse Transcription Enzyme Inhibitors
2.1.4 Hiv Integrated Enzyme Chain Transfer Inhibitor
2.2 Global HIV Therapy Drug Market Size by Type
2.2.1 Global HIV Therapy Drug Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global HIV Therapy Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global HIV Therapy Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States HIV Therapy Drug Market Size by Type
2.3.1 United States HIV Therapy Drug Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States HIV Therapy Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States HIV Therapy Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 HIV Therapy Drug Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Pharmacy
3.2 Global HIV Therapy Drug Market Size by Application
3.2.1 Global HIV Therapy Drug Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global HIV Therapy Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global HIV Therapy Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States HIV Therapy Drug Market Size by Application
3.3.1 United States HIV Therapy Drug Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States HIV Therapy Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States HIV Therapy Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global HIV Therapy Drug Competitor Landscape by Company
4.1 Global HIV Therapy Drug Market Size by Company
4.1.1 Top Global HIV Therapy Drug Manufacturers Ranked by Revenue (2021)
4.1.2 Global HIV Therapy Drug Revenue by Manufacturer (2017-2022)
4.1.3 Global HIV Therapy Drug Sales by Manufacturer (2017-2022)
4.1.4 Global HIV Therapy Drug Price by Manufacturer (2017-2022)
4.2 Global HIV Therapy Drug Concentration Ratio (CR)
4.2.1 HIV Therapy Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of HIV Therapy Drug in 2021
4.2.3 Global HIV Therapy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global HIV Therapy Drug Manufacturing Base Distribution, Product Type
4.3.1 Global HIV Therapy Drug Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers HIV Therapy Drug Product Type
4.3.3 Date of International Manufacturers Enter into HIV Therapy Drug Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States HIV Therapy Drug Market Size by Company
4.5.1 Top HIV Therapy Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States HIV Therapy Drug Revenue by Players (2020, 2021 & 2022)
4.5.3 United States HIV Therapy Drug Sales by Players (2020, 2021 & 2022)
5 Global HIV Therapy Drug Market Size by Region
5.1 Global HIV Therapy Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global HIV Therapy Drug Market Size in Volume by Region (2017-2028)
5.2.1 Global HIV Therapy Drug Sales in Volume by Region: 2017-2022
5.2.2 Global HIV Therapy Drug Sales in Volume Forecast by Region (2023-2028)
5.3 Global HIV Therapy Drug Market Size in Value by Region (2017-2028)
5.3.1 Global HIV Therapy Drug Sales in Value by Region: 2017-2022
5.3.2 Global HIV Therapy Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America HIV Therapy Drug Market Size YoY Growth 2017-2028
6.1.2 North America HIV Therapy Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific HIV Therapy Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific HIV Therapy Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe HIV Therapy Drug Market Size YoY Growth 2017-2028
6.3.2 Europe HIV Therapy Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America HIV Therapy Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America HIV Therapy Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa HIV Therapy Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa HIV Therapy Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 ViiV Healthcare
7.1.1 ViiV Healthcare Corporation Information
7.1.2 ViiV Healthcare Description and Business Overview
7.1.3 ViiV Healthcare HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 ViiV Healthcare HIV Therapy Drug Products Offered
7.1.5 ViiV Healthcare Recent Development
7.2 Gilead Sciences, Inc
7.2.1 Gilead Sciences, Inc Corporation Information
7.2.2 Gilead Sciences, Inc Description and Business Overview
7.2.3 Gilead Sciences, Inc HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Gilead Sciences, Inc HIV Therapy Drug Products Offered
7.2.5 Gilead Sciences, Inc Recent Development
7.3 AbbVie Inc.
7.3.1 AbbVie Inc. Corporation Information
7.3.2 AbbVie Inc. Description and Business Overview
7.3.3 AbbVie Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 AbbVie Inc. HIV Therapy Drug Products Offered
7.3.5 AbbVie Inc. Recent Development
7.4 Merck & Co
7.4.1 Merck & Co Corporation Information
7.4.2 Merck & Co Description and Business Overview
7.4.3 Merck & Co HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Merck & Co HIV Therapy Drug Products Offered
7.4.5 Merck & Co Recent Development
7.5 GSK
7.5.1 GSK Corporation Information
7.5.2 GSK Description and Business Overview
7.5.3 GSK HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.5.4 GSK HIV Therapy Drug Products Offered
7.5.5 GSK Recent Development
7.6 Bristol-Myers Squibb Company
7.6.1 Bristol-Myers Squibb Company Corporation Information
7.6.2 Bristol-Myers Squibb Company Description and Business Overview
7.6.3 Bristol-Myers Squibb Company HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Bristol-Myers Squibb Company HIV Therapy Drug Products Offered
7.6.5 Bristol-Myers Squibb Company Recent Development
7.7 Theratechnologies Inc.
7.7.1 Theratechnologies Inc. Corporation Information
7.7.2 Theratechnologies Inc. Description and Business Overview
7.7.3 Theratechnologies Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Theratechnologies Inc. HIV Therapy Drug Products Offered
7.7.5 Theratechnologies Inc. Recent Development
7.8 Roche Holding AG
7.8.1 Roche Holding AG Corporation Information
7.8.2 Roche Holding AG Description and Business Overview
7.8.3 Roche Holding AG HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Roche Holding AG HIV Therapy Drug Products Offered
7.8.5 Roche Holding AG Recent Development
7.9 Teva Pharmaceuticals
7.9.1 Teva Pharmaceuticals Corporation Information
7.9.2 Teva Pharmaceuticals Description and Business Overview
7.9.3 Teva Pharmaceuticals HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Teva Pharmaceuticals HIV Therapy Drug Products Offered
7.9.5 Teva Pharmaceuticals Recent Development
7.10 Pfizer
7.10.1 Pfizer Corporation Information
7.10.2 Pfizer Description and Business Overview
7.10.3 Pfizer HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Pfizer HIV Therapy Drug Products Offered
7.10.5 Pfizer Recent Development
7.11 Frontier Biotechnologies
7.11.1 Frontier Biotechnologies Corporation Information
7.11.2 Frontier Biotechnologies Description and Business Overview
7.11.3 Frontier Biotechnologies HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Frontier Biotechnologies HIV Therapy Drug Products Offered
7.11.5 Frontier Biotechnologies Recent Development
7.12 Shionogi
7.12.1 Shionogi Corporation Information
7.12.2 Shionogi Description and Business Overview
7.12.3 Shionogi HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Shionogi Products Offered
7.12.5 Shionogi Recent Development
7.13 Janssen Pharmaceuticals, Inc.
7.13.1 Janssen Pharmaceuticals, Inc. Corporation Information
7.13.2 Janssen Pharmaceuticals, Inc. Description and Business Overview
7.13.3 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Janssen Pharmaceuticals, Inc. Products Offered
7.13.5 Janssen Pharmaceuticals, Inc. Recent Development
7.14 Mylan Pharmaceuticals Inc.
7.14.1 Mylan Pharmaceuticals Inc. Corporation Information
7.14.2 Mylan Pharmaceuticals Inc. Description and Business Overview
7.14.3 Mylan Pharmaceuticals Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Mylan Pharmaceuticals Inc. Products Offered
7.14.5 Mylan Pharmaceuticals Inc. Recent Development
7.15 Genentech, Inc.
7.15.1 Genentech, Inc. Corporation Information
7.15.2 Genentech, Inc. Description and Business Overview
7.15.3 Genentech, Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Genentech, Inc. Products Offered
7.15.5 Genentech, Inc. Recent Development
7.16 Boehringer Ingelheim
7.16.1 Boehringer Ingelheim Corporation Information
7.16.2 Boehringer Ingelheim Description and Business Overview
7.16.3 Boehringer Ingelheim HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Boehringer Ingelheim Products Offered
7.16.5 Boehringer Ingelheim Recent Development
7.17 Cipla
7.17.1 Cipla Corporation Information
7.17.2 Cipla Description and Business Overview
7.17.3 Cipla HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Cipla Products Offered
7.17.5 Cipla Recent Development
7.18 MSD
7.18.1 MSD Corporation Information
7.18.2 MSD Description and Business Overview
7.18.3 MSD HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.18.4 MSD Products Offered
7.18.5 MSD Recent Development
7.19 Abbott
7.19.1 Abbott Corporation Information
7.19.2 Abbott Description and Business Overview
7.19.3 Abbott HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Abbott Products Offered
7.19.5 Abbott Recent Development
7.20 Johnson & Johnson
7.20.1 Johnson & Johnson Corporation Information
7.20.2 Johnson & Johnson Description and Business Overview
7.20.3 Johnson & Johnson HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.20.4 Johnson & Johnson Products Offered
7.20.5 Johnson & Johnson Recent Development
7.21 Biocon Limited
7.21.1 Biocon Limited Corporation Information
7.21.2 Biocon Limited Description and Business Overview
7.21.3 Biocon Limited HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.21.4 Biocon Limited Products Offered
7.21.5 Biocon Limited Recent Development
7.22 Affine Formulations Limited
7.22.1 Affine Formulations Limited Corporation Information
7.22.2 Affine Formulations Limited Description and Business Overview
7.22.3 Affine Formulations Limited HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.22.4 Affine Formulations Limited Products Offered
7.22.5 Affine Formulations Limited Recent Development
7.23 IPCA Laboratories
7.23.1 IPCA Laboratories Corporation Information
7.23.2 IPCA Laboratories Description and Business Overview
7.23.3 IPCA Laboratories HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.23.4 IPCA Laboratories Products Offered
7.23.5 IPCA Laboratories Recent Development
7.24 Natco Pharma
7.24.1 Natco Pharma Corporation Information
7.24.2 Natco Pharma Description and Business Overview
7.24.3 Natco Pharma HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.24.4 Natco Pharma Products Offered
7.24.5 Natco Pharma Recent Development
7.25 Beacon Pharmaceuticals
7.25.1 Beacon Pharmaceuticals Corporation Information
7.25.2 Beacon Pharmaceuticals Description and Business Overview
7.25.3 Beacon Pharmaceuticals HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.25.4 Beacon Pharmaceuticals Products Offered
7.25.5 Beacon Pharmaceuticals Recent Development
7.26 Julphar Bangladesh
7.26.1 Julphar Bangladesh Corporation Information
7.26.2 Julphar Bangladesh Description and Business Overview
7.26.3 Julphar Bangladesh HIV Therapy Drug Sales, Revenue and Gross Margin (2017-2022)
7.26.4 Julphar Bangladesh Products Offered
7.26.5 Julphar Bangladesh Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 HIV Therapy Drug Industry Chain Analysis
8.2 HIV Therapy Drug Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 HIV Therapy Drug Distributors
8.3 HIV Therapy Drug Production Mode & Process
8.4 HIV Therapy Drug Sales and Marketing
8.4.1 HIV Therapy Drug Sales Channels
8.4.2 HIV Therapy Drug Distributors
8.5 HIV Therapy Drug Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. HIV Therapy Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. HIV Therapy Drug Market Trends
    Table 3. HIV Therapy Drug Market Drivers
    Table 4. HIV Therapy Drug Market Challenges
    Table 5. HIV Therapy Drug Market Restraints
    Table 6. Global HIV Therapy Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States HIV Therapy Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global HIV Therapy Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States HIV Therapy Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top HIV Therapy Drug Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global HIV Therapy Drug Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global HIV Therapy Drug Revenue Share by Manufacturer, 2017-2022
    Table 13. Global HIV Therapy Drug Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global HIV Therapy Drug Sales Share by Manufacturer, 2017-2022
    Table 15. Global HIV Therapy Drug Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global HIV Therapy Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global HIV Therapy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Therapy Drug as of 2021)
    Table 18. Top Players of HIV Therapy Drug in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers HIV Therapy Drug Product Type
    Table 20. Date of International Manufacturers Enter into HIV Therapy Drug Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top HIV Therapy Drug Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States HIV Therapy Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States HIV Therapy Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States HIV Therapy Drug Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States HIV Therapy Drug Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global HIV Therapy Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global HIV Therapy Drug Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global HIV Therapy Drug Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global HIV Therapy Drug Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global HIV Therapy Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America HIV Therapy Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America HIV Therapy Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific HIV Therapy Drug Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific HIV Therapy Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe HIV Therapy Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe HIV Therapy Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America HIV Therapy Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa HIV Therapy Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa HIV Therapy Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa HIV Therapy Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. ViiV Healthcare Corporation Information
    Table 43. ViiV Healthcare Description and Business Overview
    Table 44. ViiV Healthcare HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. ViiV Healthcare HIV Therapy Drug Product
    Table 46. ViiV Healthcare Recent Development
    Table 47. Gilead Sciences, Inc Corporation Information
    Table 48. Gilead Sciences, Inc Description and Business Overview
    Table 49. Gilead Sciences, Inc HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Gilead Sciences, Inc Product
    Table 51. Gilead Sciences, Inc Recent Development
    Table 52. AbbVie Inc. Corporation Information
    Table 53. AbbVie Inc. Description and Business Overview
    Table 54. AbbVie Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. AbbVie Inc. Product
    Table 56. AbbVie Inc. Recent Development
    Table 57. Merck & Co Corporation Information
    Table 58. Merck & Co Description and Business Overview
    Table 59. Merck & Co HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Merck & Co Product
    Table 61. Merck & Co Recent Development
    Table 62. GSK Corporation Information
    Table 63. GSK Description and Business Overview
    Table 64. GSK HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. GSK Product
    Table 66. GSK Recent Development
    Table 67. Bristol-Myers Squibb Company Corporation Information
    Table 68. Bristol-Myers Squibb Company Description and Business Overview
    Table 69. Bristol-Myers Squibb Company HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Bristol-Myers Squibb Company Product
    Table 71. Bristol-Myers Squibb Company Recent Development
    Table 72. Theratechnologies Inc. Corporation Information
    Table 73. Theratechnologies Inc. Description and Business Overview
    Table 74. Theratechnologies Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Theratechnologies Inc. Product
    Table 76. Theratechnologies Inc. Recent Development
    Table 77. Roche Holding AG Corporation Information
    Table 78. Roche Holding AG Description and Business Overview
    Table 79. Roche Holding AG HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Roche Holding AG Product
    Table 81. Roche Holding AG Recent Development
    Table 82. Teva Pharmaceuticals Corporation Information
    Table 83. Teva Pharmaceuticals Description and Business Overview
    Table 84. Teva Pharmaceuticals HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Teva Pharmaceuticals Product
    Table 86. Teva Pharmaceuticals Recent Development
    Table 87. Pfizer Corporation Information
    Table 88. Pfizer Description and Business Overview
    Table 89. Pfizer HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Pfizer Product
    Table 91. Pfizer Recent Development
    Table 92. Frontier Biotechnologies Corporation Information
    Table 93. Frontier Biotechnologies Description and Business Overview
    Table 94. Frontier Biotechnologies HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Frontier Biotechnologies Product
    Table 96. Frontier Biotechnologies Recent Development
    Table 97. Shionogi Corporation Information
    Table 98. Shionogi Description and Business Overview
    Table 99. Shionogi HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. Shionogi Product
    Table 101. Shionogi Recent Development
    Table 102. Janssen Pharmaceuticals, Inc. Corporation Information
    Table 103. Janssen Pharmaceuticals, Inc. Description and Business Overview
    Table 104. Janssen Pharmaceuticals, Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 105. Janssen Pharmaceuticals, Inc. Product
    Table 106. Janssen Pharmaceuticals, Inc. Recent Development
    Table 107. Mylan Pharmaceuticals Inc. Corporation Information
    Table 108. Mylan Pharmaceuticals Inc. Description and Business Overview
    Table 109. Mylan Pharmaceuticals Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 110. Mylan Pharmaceuticals Inc. Product
    Table 111. Mylan Pharmaceuticals Inc. Recent Development
    Table 112. Genentech, Inc. Corporation Information
    Table 113. Genentech, Inc. Description and Business Overview
    Table 114. Genentech, Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 115. Genentech, Inc. Product
    Table 116. Genentech, Inc. Recent Development
    Table 117. Boehringer Ingelheim Corporation Information
    Table 118. Boehringer Ingelheim Description and Business Overview
    Table 119. Boehringer Ingelheim HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 120. Boehringer Ingelheim Product
    Table 121. Boehringer Ingelheim Recent Development
    Table 122. Cipla Corporation Information
    Table 123. Cipla Description and Business Overview
    Table 124. Cipla HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 125. Cipla Product
    Table 126. Cipla Recent Development
    Table 127. MSD Corporation Information
    Table 128. MSD Description and Business Overview
    Table 129. MSD HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 130. MSD Product
    Table 131. MSD Recent Development
    Table 132. Abbott Corporation Information
    Table 133. Abbott Description and Business Overview
    Table 134. Abbott HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 135. Abbott Product
    Table 136. Abbott Recent Development
    Table 137. Johnson & Johnson Corporation Information
    Table 138. Johnson & Johnson Description and Business Overview
    Table 139. Johnson & Johnson HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 140. Johnson & Johnson Product
    Table 141. Johnson & Johnson Recent Development
    Table 142. Biocon Limited Corporation Information
    Table 143. Biocon Limited Description and Business Overview
    Table 144. Biocon Limited HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 145. Biocon Limited Product
    Table 146. Biocon Limited Recent Development
    Table 147. Affine Formulations Limited Corporation Information
    Table 148. Affine Formulations Limited Description and Business Overview
    Table 149. Affine Formulations Limited HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 150. Affine Formulations Limited Product
    Table 151. Affine Formulations Limited Recent Development
    Table 152. IPCA Laboratories Corporation Information
    Table 153. IPCA Laboratories Description and Business Overview
    Table 154. IPCA Laboratories HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 155. IPCA Laboratories Product
    Table 156. IPCA Laboratories Recent Development
    Table 157. Natco Pharma Corporation Information
    Table 158. Natco Pharma Description and Business Overview
    Table 159. Natco Pharma HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 160. Natco Pharma Product
    Table 161. Natco Pharma Recent Development
    Table 162. Beacon Pharmaceuticals Corporation Information
    Table 163. Beacon Pharmaceuticals Description and Business Overview
    Table 164. Beacon Pharmaceuticals HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 165. Beacon Pharmaceuticals Product
    Table 166. Beacon Pharmaceuticals Recent Development
    Table 167. Julphar Bangladesh Corporation Information
    Table 168. Julphar Bangladesh Description and Business Overview
    Table 169. Julphar Bangladesh HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 170. Julphar Bangladesh Product
    Table 171. Julphar Bangladesh Recent Development
    Table 172. Key Raw Materials Lists
    Table 173. Raw Materials Key Suppliers Lists
    Table 174. HIV Therapy Drug Customers List
    Table 175. HIV Therapy Drug Distributors List
    Table 176. Research Programs/Design for This Report
    Table 177. Key Data Information from Secondary Sources
    Table 178. Key Data Information from Primary Sources
List of Figures
    Figure 1. HIV Therapy Drug Product Picture
    Figure 2. Global HIV Therapy Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global HIV Therapy Drug Market Size 2017-2028 (US$ Million)
    Figure 4. Global HIV Therapy Drug Sales 2017-2028 (K Units)
    Figure 5. United States HIV Therapy Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States HIV Therapy Drug Market Size 2017-2028 (US$ Million)
    Figure 7. United States HIV Therapy Drug Sales 2017-2028 (K Units)
    Figure 8. United States HIV Therapy Drug Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States HIV Therapy Drug Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. HIV Therapy Drug Report Years Considered
    Figure 11. Product Picture of Multi-Type Combined Drugs
    Figure 12. Product Picture of Nucleoside Reverse Transcription Enzyme Inhibitors
    Figure 13. Product Picture of Non-Nucleoside Reverse Transcription Enzyme Inhibitors
    Figure 14. Product Picture of Hiv Integrated Enzyme Chain Transfer Inhibitor
    Figure 15. Global HIV Therapy Drug Market Share by Type in 2022 & 2028
    Figure 16. Global HIV Therapy Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global HIV Therapy Drug Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global HIV Therapy Drug Sales by Type (2017-2028) & (K Units)
    Figure 19. Global HIV Therapy Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global HIV Therapy Drug Price by Type (2017-2028) & (US$/Unit)
    Figure 21. United States HIV Therapy Drug Market Share by Type in 2022 & 2028
    Figure 22. United States HIV Therapy Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States HIV Therapy Drug Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States HIV Therapy Drug Sales by Type (2017-2028) & (K Units)
    Figure 25. United States HIV Therapy Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States HIV Therapy Drug Price by Type (2017-2028) & (US$/Unit)
    Figure 27. Product Picture of Hospital
    Figure 28. Product Picture of Clinic
    Figure 29. Product Picture of Pharmacy
    Figure 30. Global HIV Therapy Drug Market Share by Application in 2022 & 2028
    Figure 31. Global HIV Therapy Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global HIV Therapy Drug Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global HIV Therapy Drug Sales by Application (2017-2028) & (K Units)
    Figure 34. Global HIV Therapy Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global HIV Therapy Drug Price by Application (2017-2028) & (US$/Unit)
    Figure 36. United States HIV Therapy Drug Market Share by Application in 2022 & 2028
    Figure 37. United States HIV Therapy Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States HIV Therapy Drug Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States HIV Therapy Drug Sales by Application (2017-2028) & (K Units)
    Figure 40. United States HIV Therapy Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States HIV Therapy Drug Price by Application (2017-2028) & (US$/Unit)
    Figure 42. North America HIV Therapy Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 43. North America HIV Therapy Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. United States HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe HIV Therapy Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 47. Europe HIV Therapy Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific HIV Therapy Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 54. Asia-Pacific HIV Therapy Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. China Taiwan HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America HIV Therapy Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 65. Latin America HIV Therapy Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Colombia HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa HIV Therapy Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 71. Middle East & Africa HIV Therapy Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. UAE HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. HIV Therapy Drug Value Chain
    Figure 76. HIV Therapy Drug Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS